Company: PED
Filing Date: 2025-10-31
Form Type: 10-K/A
Source: 0001654954-25-012381
Chunk: 162

Company: PEDEVCO CORP
Filing Date: 2025-10-31
Form: 10-K/A
Chunk 162
---
 vesting terms described above. When such securities are vested in accordance with their terms, the trading restrictions are lifted.

Stock-based compensation expense recorded related to restricted stock during the years ended December 31, 2024 and 2023 was $ and $, respectively. The remaining amount of unamortized stock-based compensation expense related to restricted stock at December 31, 2024 and 2023 was $ and $, respectively.

| 111 |

Options

On January 26, 2024, the Company granted options to purchase an aggregate of shares of common stock to various Company employees at an exercise price of $ per share under the Company’s 2021 Plan. . The aggregate fair value of the options on the date of grant, using the Black-Scholes model, was $. Variables used in the Black-Scholes option-pricing model for the options issued include: (1) a discount rate of % based on the applicable US Treasury bill rate, (2) expected term of years, (3) expected volatility of % based on the trading history of the Company, and (4) zero expected dividends.

During the period ended December 31, 2024, options were rescinded due to an employee termination. As a result, these options once again became eligible for future awards under the Company’s Amended and Restated 2012 and 2021 Plans.

On January 23, 2023, the Company granted options to purchase an aggregate of shares of common stock to various Company employees at an exercise price of $ per share under the Company’s 2021 Plan. . The aggregate fair value of the options on the date of grant, using the Black-Scholes model, was $. Variables used in the Black-Scholes option-pricing model for the options issued include: (1) a discount rate of % based on the applicable US Treasury bill rate, (2) expected term of years, (3) expected volatility of % based on the trading history of the Company, and (4) zero expected dividends.

During the period ended December 31, 2023, options expired unexercised.

During the year ended December 31, 2024 and 2023, the Company recognized stock option-based compensation expense related to options of $ and $, respectively.

The remaining amount of unamortized stock options expense at December 31, 2024 and 2023 was $ and $, respectively.

There was no intrinsic value of outstanding and exercisable options at December